English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Mechanical thrombectomy (MT) is an experimental interventional treatment for ischaemic stroke in the UK [1], which has been shown to offer increased rates of recanalisation in cases of large vessel occlusion compared to IV treatment alone or combined IV/IA thrombolysis [2]. Early randomised controlled trials failed to show benefit comparing MT to conventional treatment [3-6], but these trials were criticized for failing to optimise patient selection [7] and used older devices. Recently, four new large randomised controlled trials addressing these issues have proven significant benefit in functional outcome for MT over IV thrombolysis in selected patient groups [8-11].

soj neurology

Differences in Factors Predicting Outcome and Mortality after Mechanical Thrombectomy for Acute Large Vessel Stroke Between Patients over and Under 70 Years of Age: A Five Year Retrospective Study